Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Robert Modlin, M.D.
Robert Modlin, M.D.



General Information:



Professor and Chief, Department of Medicine, Dermatology
Member, ACCESS Department - Microbiology, Immunology and Molecular Genetics
Member, JCCC Tumor Immunology Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center


Medicine/Dermatology, LAC+USC Medical Center, 1981 - 1984
Pediatrics, New York University Medical Center, 1980 - 1981
Medical Degree:
M.D., New York University School of Medicine, 1980


Board Certification(s):
Dermatology, American Board of Dermatology, 1984

Contact Information:

(310) 825-6214 or (310) 825-5420
(310) 917-3376 Dermatology information and referral

Practice Information:

Clinical Interest(s):
General Dermatology

Scientific Interest(s):

Infectious disease poses a major health problem worldwide. Essential to the control of these diseases is the elucidation of immune mechanisms which result in resistance versus susceptibility to infection. Dr. Robert Modlin's laboratory focuses on the identification of novel mechanisms by which the innate and adaptive immune system combat microbial pathogens.

Mammalian Toll-like receptors comprise part of the innate response. The researchers study the microbial ligands that activate Toll-like receptors and the functional consequence of Toll activation. Modlin and his colleagues are interested in the mechanism by which Toll activation influences the adaptive T-cell response, the mechanisms by which Toll activation leads to direct antimicrobial pathways and role of Toll like receptors in causing tissue injury in disease. The adaptive T-cell response recognizes peptide antigens in the context of MHC molecules and lipid antigens presented by CD1 molecules. The researchers are identifying novel peptide and lipid antigens that are immunodominant in the human immune response to infection as well as mechanisms by which these T-cells can directly kill the foreign invader. Using the knowledge of these antigen presentation pathways, the researchers are engineering new vaccine strategies against these pathogens. It is hoped that the insights obtained from these studies will lead to better treatments and prevention of infectious diseases in humans.

Selected Cancer-Related Publications:

Liu PT, Krutzik SR, Modlin RL. Therapeutic implications of the TLR and VDR partnership. Trends Mol Med. 2007; 13(3): 117-24.

Miller LS, Modlin RL. Human keratinocyte Toll-like receptors promote distinct immune responses. J Invest Dermatol. 2007; 127(2): 262-3.

Modlin R. The vitamin D receptor and its role in inflammation and host defence: interview with Dr Robert Modlin by Emma Quigley. Expert Opin Ther Targets. 2007; 11(4): 431-3.

Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, Helfrich YR, Kang S, Elalieh HZ, Steinmeyer A, Zugel U, Bikle DD, Modlin RL, Gallo RL. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest. 2007; 117(3): 803-11.

Sieling PA, Legaspi A, Ochoa MT, Rea TH, Modlin RL. Regulation of human T-cell homing receptor expression in cutaneous bacterial infection. Immunology. 2007; 120(4): 518-25.